Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.49 USD
−5.77 M USD
17.47 M USD
5.31 M
About ImmuCell Corporation
Sector
Industry
CEO
Michael F. Brigham
Website
Headquarters
Portland
Founded
1982
FIGI
BBG000BLQ5Q2
ImmuCell Corp. engages in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kits, and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ICCC is 3.66 USD — it hasn't changed in the past 24 hours. Watch ImmuCell Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ImmuCell Corporation stocks are traded under the ticker ICCC.
ICCC stock has fallen by −2.70% compared to the previous week, the month change is a −1.37% fall, over the last year ImmuCell Corporation has showed a −20.20% decrease.
ICCC reached its all-time high on Jun 29, 1987 with the price of 15.63 USD, and its all-time low was 0.41 USD and was reached on Jan 8, 1991. View more price dynamics on ICCC chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ICCC stock is 5.62% volatile and has beta coefficient of −0.23. Track ImmuCell Corporation stock price on the chart and check out the list of the most volatile stocks — is ImmuCell Corporation there?
Yes, you can track ImmuCell Corporation financials in yearly and quarterly reports right on TradingView.
ImmuCell Corporation is going to release the next earnings report on Feb 25, 2025. Keep track of upcoming events with our Earnings Calendar.
ICCC net income for the last quarter is −701.69 K USD, while the quarter before that showed −1.53 M USD of net income which accounts for 54.19% change. Track more ImmuCell Corporation financial stats to get the full picture.
No, ICCC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 79.00 employees. See our rating of the largest employees — is ImmuCell Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ImmuCell Corporation EBITDA is −566.22 K USD, and current EBITDA margin is −17.35%. See more stats in ImmuCell Corporation financial statements.
Like other stocks, ICCC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ImmuCell Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ImmuCell Corporation technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ImmuCell Corporation stock shows the sell signal. See more of ImmuCell Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.